China Universal Asset Management »

Monte Rosa Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $228k 31k 7.41
2025-06-30 $146k 32k 4.51
2025-03-31 $57k 12k 4.64
2024-12-31 $90k 13k 6.94
2023-09-30 $6.1k 1.3k 4.79
2023-06-30 $4.4k 647 6.85
2023-03-31 $5.1k 656 7.79
2022-12-31 $3.7k 492 7.61
2022-09-30 $4.0k 437 9.15

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics